Roseola: Difference between revisions
Jump to navigation
Jump to search
Usama Talib (talk | contribs) No edit summary |
m Bot: Removing from Primary care |
||
(2 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
'''For patient information click [[Roseola (patient information)|here]]''' | '''For patient information click [[Roseola (patient information)|here]]''' | ||
<small> | |||
{{Infobox Disease | | {{Infobox Disease | | ||
Name = Roseola | | Name = Roseola | | ||
Line 7: | Line 8: | ||
Caption = Maculopapular rash as seen in an infant. | | Caption = Maculopapular rash as seen in an infant. | | ||
}} | }} | ||
</small> | </small> | ||
{{Roseola}} | {{Roseola}} | ||
{{CMG}}:{{AE}}{{DAMI}} | {{CMG}}:{{AE}}{{DAMI}} | ||
Line 40: | Line 42: | ||
==Case Studies== | ==Case Studies== | ||
[[Roseola case study one|Case #1]] | [[Roseola case study one|Case #1]] | ||
[[Category:Emergency mdicine]] | |||
[[Category:Disease]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | |||
[[Category:Neurology]] | |||
[[Category:Pediatrics]] | |||
[[Category:Dermatology]] |
Latest revision as of 00:02, 30 July 2020
For patient information click here
Roseola | |
Maculopapular rash as seen in an infant. |
Roseola Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Roseola On the Web |
American Roentgen Ray Society Images of Roseola |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]:Associate Editor(s)-in-Chief: Omodamola Aje B.Sc, M.D. [2]
Synonyms and keywords: Roseola infantum, exanthem subitum, sixth disease, 3 day rash, pseudorubella, exanthem criticum
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Any Disease from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | X Ray | CT | MRI | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies